Today: 22 May 2026
AMD stock today: Shares edge higher as traders eye Lisa Su’s CES keynote
31 December 2025
2 mins read

AMD stock today: Shares edge higher as traders eye Lisa Su’s CES keynote

NEW YORK, December 31, 2025, 11:58 ET — Regular session

  • AMD shares up about 0.3% in late-morning trade on the final session of 2025
  • Focus shifts to CES next week and early-2026 product and AI-roadmap signals
  • Chip stocks mixed as broader U.S. indexes drift lower in holiday-thin trading

Shares of Advanced Micro Devices rose about 0.3% to $215.92 in late-morning trading on Wednesday. The stock has ranged from $213.61 to $217.54 so far in the session.

The move comes with investors squaring year-end positions and looking ahead to near-term catalysts in early January, including AMD’s scheduled appearance at the CES tech show in Las Vegas.

AMD heads into the close of 2025 after a sharp run that has shifted attention toward what comes next in the AI chip race. MarketWatch reported the stock has gained about 78% this year, putting a premium on execution in 2026.

Wall Street’s main indexes edged lower on the final trading day of the year, weighed by weakness in parts of the tech sector, Reuters reported. U.S. markets will be closed on Thursday for New Year’s Day.

Chip stocks were mixed. The PHLX Semiconductor Index was down about 0.4%, while Nvidia rose about 0.7% and Intel slipped about 0.1%.

AI-chip demand headlines also stayed in focus. Investors.com reported Nvidia asked Taiwan Semiconductor to boost output of its H200 data-center GPUs amid demand from China.

Analysts continue to frame AMD’s next major test as the rollout of newer AI hardware. In a note cited by MarketWatch, TD Cowen analyst Joshua Buchalter said launches of AMD’s Instinct MI450 accelerators and Helios rack-scale systems “will mark a key inflection point” for the company’s stock and earnings. MarketWatch

AI accelerators are specialized chips built to handle the heavy computing used to train and run AI models. “Rack-scale” refers to packaging chips, networking and software into full server-rack systems aimed at large data centers.

AMD has also flagged CES as a near-term stage for its messaging. The company said CEO Lisa Su will deliver the CES 2026 opening keynote on Jan. 5 at 9:30 p.m. ET, with updates on AI solutions “from cloud to enterprise, edge and devices.” AMD

For investors, CES can offer early signals on AMD’s client PC, gaming and AI-PC direction, but the central debate remains in data centers. Nvidia’s advantage rests heavily on CUDA — its widely used developer software platform — which helps lock in AI workloads even when rivals offer competitive hardware.

Attention also turns to the next quarterly report for harder numbers. Yahoo Finance’s earnings calendar lists Feb. 3 after the close for AMD’s next results, with investors likely to focus on data-center demand, gross margin and management’s 2026 outlook.

With stocks closed on New Year’s Day and holiday-thin trading still shaping price action, AMD enters 2026 with catalyst risk front-loaded into early January. The next leg, investors say, will come down to execution — product details, software support and customer deployments — rather than the 2025 rally alone.

Stock Market Today

  • Q1 Earnings Review: Azenta Falls; West Pharmaceutical Leads Drug Development Services Stocks
    May 21, 2026, 9:31 PM EDT. Drug development inputs and services stocks, essential for pharmaceutical research and manufacturing, reported mixed Q1 results. Azenta (NASDAQ:AZTA), specializing in biological sample management, posted disappointing results with $144.8 million revenue, missing estimates and the weakest among peers, causing its share price to drop 23.4% to $17.65. Conversely, West Pharmaceutical Services (NYSE:WST), maker of specialized packaging and delivery devices, delivered a strong quarter with $844.9 million revenue, beating estimates by 8.4%. Overall, the sector's revenues beat consensus by 1.6%, despite an average 2.5% share price decline post-earnings. Tailwinds include growth in biologics and gene therapies, while headwinds feature pricing pressure and regulatory risks.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
Rivian stock slips in premarket as Tesla delivery report looms on year-end session
Previous Story

Rivian stock slips in premarket as Tesla delivery report looms on year-end session

XRP price today: Ripple-linked token slips as year-end trading thins — key levels before 2026
Next Story

XRP price today: Ripple-linked token slips as year-end trading thins — key levels before 2026

Go toTop